Surf AccountsProduction v1.0.0 v1.0.0 2022-05-01 The company was not dormant during the period The company was trading for the entire period Unaudited Accounts The principal activity of the Company is the provision of medical services. 18 October 2023 1 1 09005440 2023-04-30 09005440 2022-04-30 09005440 2021-04-30 09005440 2022-05-01 2023-04-30 09005440 2021-05-01 2022-04-30 09005440 uk-bus:PrivateLimitedCompanyLtd 2022-05-01 2023-04-30 09005440 uk-curr:PoundSterling 2022-05-01 2023-04-30 09005440 uk-bus:AbridgedAccounts 2022-05-01 2023-04-30 09005440 uk-core:ShareCapital 2023-04-30 09005440 uk-core:ShareCapital 2022-04-30 09005440 uk-core:RetainedEarningsAccumulatedLosses 2023-04-30 09005440 uk-core:RetainedEarningsAccumulatedLosses 2022-04-30 09005440 uk-core:TotalEquityAttributableToOwnersParentBeforeNon-controllingInterests 2023-04-30 09005440 uk-core:TotalEquityAttributableToOwnersParentBeforeNon-controllingInterests 2022-04-30 09005440 uk-bus:FRS102 2022-05-01 2023-04-30 09005440 uk-core:PlantMachinery 2022-05-01 2023-04-30 09005440 2022-05-01 2023-04-30 09005440 uk-bus:Director1 2022-05-01 2023-04-30 09005440 uk-bus:AuditExempt-NoAccountantsReport 2022-05-01 2023-04-30 xbrli:pure iso4217:GBP xbrli:shares
 
 
 
A2E Medical Services Ltd
 
Abridged Unaudited Financial Statements
 
for the financial year ended 30 April 2023



A2E Medical Services Ltd
Company Registration Number: 09005440
ABRIDGED BALANCE SHEET
as at 30 April 2023

2023 2022
Notes £ £
 
Fixed Assets
Tangible assets 4 4,026 5,032
───────── ─────────
 
Current Assets
Debtors 1,694 1,443
Cash and cash equivalents 23,387 4,310
───────── ─────────
25,081 5,753
───────── ─────────
Creditors: amounts falling due within one year (15,644) (18,629)
───────── ─────────
Net Current Assets/(Liabilities) 9,437 (12,876)
───────── ─────────
Total Assets less Current Liabilities 13,463 (7,844)
═════════ ═════════
 
Capital and Reserves
Called up share capital 1,000 1,000
Retained earnings 12,463 (8,844)
───────── ─────────
Equity attributable to owners of the company 13,463 (7,844)
═════════ ═════════
 
The financial statements have been prepared in accordance with the provisions applicable to companies subject to the small companies' regime and in accordance with the provisions of FRS 102 Section 1A (Small Entities).
           
All of the members have consented to the preparation of abridged accounts in accordance with section 444(2A) of the Companies Act 2006.
           
The company has taken advantage of the exemption under section 444 not to file the Abridged Profit and Loss Account and Director's Report.
For the financial year ended 30 April 2023 the company was entitled to exemption from audit under section 477 of the Companies Act 2006.
           
The director confirms that the members have not required the company to obtain an audit of its financial statements for the financial year in question in accordance with section 476 of the Companies Act 2006.
           
The director acknowledges their responsibilities for ensuring that the company keeps accounting records which comply with section 386 and for preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of the financial year and of its profit and loss for the financial year in accordance with the requirements of sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.
           
Approved by the Director and authorised for issue on 18 October 2023
           
           
________________________________          
Ms H J Allen          
Director          
           



A2E Medical Services Ltd
NOTES TO THE ABRIDGED FINANCIAL STATEMENTS
for the financial year ended 30 April 2023

   
1. General Information
 
A2E Medical Services Ltd is a company limited by shares incorporated in the United Kingdom. The registered office of the company is Oldlands, 105 Easton Street, Portland, Dorset, DT5 1BP, United Kingdom which is also the principal place of business of the company. The principal activity of the Company is the provision of medical services. The financial statements have been presented in Pound (£) which is also the functional currency of the company.
         
2. Summary of Significant Accounting Policies
 
The following accounting policies have been applied consistently in dealing with items which are considered material in relation to the company's financial statements.
 
Statement of compliance
The financial statements of the company for the year ended 30 April 2023 have been prepared in accordance with the provisions of FRS 102 Section 1A (Small Entities) and the Companies Act 2006.
 
Basis of preparation
The financial statements have been prepared on the going concern basis and in accordance with the historical cost convention except for certain properties and financial instruments that are measured at revalued amounts or fair values, as explained in the accounting policies below. Historical cost is generally based on the fair value of the consideration given in exchange for assets.
 
Turnover
Turnover comprises the invoice value of goods supplied by the company, exclusive of trade discounts and value added tax.
 
Tangible assets and depreciation
Tangible assets are stated at cost or at valuation, less accumulated depreciation. The charge to depreciation is calculated to write off the original cost or valuation of tangible assets, less their estimated residual value, over their expected useful lives as follows:
 
  Plant and machinery - 20% Reducing balance
 
The carrying values of tangible fixed assets are reviewed annually for impairment in periods if events or changes in circumstances indicate the carrying value may not be recoverable.
 
Trade and other debtors
Trade and other debtors are initially recognised at fair value and thereafter stated at amortised cost using the effective interest method less impairment losses for bad and doubtful debts except where the effect of discounting would be immaterial. In such cases the receivables are stated at cost less impairment losses for bad and doubtful debts.
 
Trade and other creditors
Trade and other creditors are initially recognised at fair value and thereafter stated at amortised cost using the effective interest rate method, unless the effect of discounting would be immaterial, in which case they are stated at cost.
 
Taxation
Current tax represents the amount expected to be paid or recovered in respect of taxable profits for the financial year and is calculated using the tax rates and laws that have been enacted or substantially enacted at the Balance Sheet date.
       
3. Employees
 
The average monthly number of employees, including director, during the financial year was 1, (2022 - 1).
 
  2023 2022
  Number Number
 
Director 1 1
  ═════════ ═════════
       
4. Tangible assets
  Plant and Total
  machinery  
     
  £ £
Cost
At 1 May 2022 18,020 18,020
  ───────── ─────────
 
At 30 April 2023 18,020 18,020
  ───────── ─────────
Depreciation
At 1 May 2022 12,988 12,988
Charge for the financial year 1,006 1,006
  ───────── ─────────
At 30 April 2023 13,994 13,994
  ───────── ─────────
Net book value
At 30 April 2023 4,026 4,026
  ═════════ ═════════
At 30 April 2022 5,032 5,032
  ═════════ ═════════
       
5. Capital commitments
 
The company had no material capital commitments at the financial year-ended 30 April 2023.
   
6. Post-Balance Sheet Events
 
There have been no significant events affecting the company since the financial year-end.